Delivery Order SPE2DB22D9316-SPE2DB25FYM62

Award Date 11/18/24
Potential Completion Date 12/10/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The firm fixed-price contract is valued at $49,600.00 and has a period of performance through May 2, 2024. The contract is for the delivery of 4,564,598,915 units of Doxycycline Hyclate 100 mg tablets in 400-count packages. This order is placed under a larger indefinite delivery contract (IDC) that DMS...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,370.16, is for the delivery of 4,564,234,742 units of doxycycline hyclate 100 mg tablets. The contract has a firm fixed-price pricing type and a period of performance through March 29, 2024. DMS Pharmaceutical Group holds a separate,...
This is a $49,600 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of pharmaceutical products to support the recurring medical supply needs of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Doxycycline Hyclate 100 mg tablets, with a ceiling value of $39,225.00 and a period of performance through April 19, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows...
This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,370.16 contract is for the delivery of Doxycycline Hyclate, a pharmaceutical product, to support the medical supply needs of the Defense Logistics Agency (DLA). The contract has an ultimate completion date of July 5, 2023. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $1,801.80, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4,565,762,357 units of doxycycline hyclate 100 mg tablets. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of $1,370.16 worth of doxycycline hyclate, a prescription medication. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, which allows the agency to issue delivery orders for a comprehensive range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $1,712.70, is for the delivery of doxycycline hyclate, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue firm fixed-price delivery orders...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,624.29, is for the delivery of doxycycline hyclate, a pharmaceutical product, with a performance period ending on June 28, 2024. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,598.52, is for the delivery of Doxycycline Hyclate, a pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the agency to order a comprehensive...
  • SPE2DB22D9316
    Indefinite Delivery Contract
  • SPE2DB22D9316-SPE2DB25FYM62
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,612.00 contract is for the delivery of 4,566,628,081 units of Doxycycline Hyclate 100 mg tablets, a pharmaceutical product used to treat a variety of bacterial infections. The contract has a period of performance through December 10, 2024 and is not associated with any set-aside designations.

DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical supplies to military healthcare facilities and veterans' medical centers. This delivery order is issued under a larger $499,999,999 Indefinite Delivery Contract (IDC) the company holds with the DLA, which enables the agency to place orders for a comprehensive portfolio of pharmaceutical products to support the medical needs of the Department of Defense.

Generated 2/17/25, 9:41 PM